Делирий у больного инфарктом миокарда

Делирий у больного инфарктом миокарда

Автор: Пантелеев О.О., Рябов В.В.

Журнал: Сибирский журнал клинической и экспериментальной медицины @cardiotomsk

Рубрика: Обзоры и лекции

Статья в выпуске: 3 т.37, 2022 года.

Бесплатный доступ

Делирий является предиктором неблагоприятного исхода как при инфаркте миокарда (ИМ), так и при других нозологиях. Несмотря на рост интереса к данной проблеме, эффективных способов прогнозирования, профилактики и лечения делирия не найдено. Данный обзор литературы освещает актуальные представления об этиологии, патогенезе делирия, подходах к профилактике и лечению, особенностях делирия у больных ИМ, содержит анализ проведенных клинических исследований и метаанализов с выявлением причин их неудач и поиском перспективных направлений для дальнейших исследований этого синдрома.

Делирий, патогенез, инфаркт миокарда

Короткий адрес: https://sciup.org/149141435

IDR: 149141435   |   DOI: 10.29001/2073-8552-2022-37-3-49-55

Список литературы Делирий у больного инфарктом миокарда

  • Amini M., Zayeri F., Salehi M. Trend analysis of cardiovascular disease mortality, incidence, and mortality-to-incidence ratio: Results from global burden of disease study 2017. BMC Public Health. 2021;21(1):401. DOI: 10.1186/s12889-021-10429-0.
  • Patil S., Gonuguntala K., Rojulpote C., Kumar M., Corradi J.P., Chen K. Delirium is an important predictor of mortality in elderly patients with ST-elevation myocardial infarction: Insight from National Inpatient Sample database. Coron. Artery Dis. 2020;31(8):665-670. DOI: 10.1097/ MCA.0000000000000978.
  • Slooter A.J.C., Otte W.M., Devlin J.W., Arora R.C., Bleck T.P., Claassen J. et al. Updated nomenclature of delirium and acute encephalopathy: Statement of ten Societies. Intensive Care Med. 2020;46(5):1020-1022. DOI: 10.1007/s00134-019-05907-4.
  • Grover S., Ghosh A., Sarkar S., Desouza A., Yaddanapudi L.N., Basu D. Delirium in Intensive Care Unit: Phenomenology, subtypes, and factor structure of symptoms. Indian J. Psychol. Med. 2018;40(2):169-177. DOI: 10.4103/IJPSYM.IJPSYM_274_17.
  • Franco J.G., Trzepacz P.T., Sepulveda E., Ocampo M.V., Velasquez-Tirado J.D., Zaraza D.R. et al. Delirium diagnostic tool-provisional (DDT-Pro) scores in delirium, subsyndromal delirium and no delirium. Gen. Hosp. Psychiatry. 2020;67:107-114. DOI: 10.1016/j.gen-hosppsych.2020.10.003.
  • Azuma K., Mishima S., Shimoyama K., Ishii Y., Ueda Y., Sakurai M. et al. Validation of the Prediction of Delirium for Intensive Care model to predict subsyndromal delirium. Acute Med. Surg. 2018;6(1):54-59. DOI: 10.1002/ams2.378.
  • Serafim R.B., Paulino M.C., Povoa P. What every intensivist needs to know about subsyndromal delirium in the intensive care unit. Rev. Bras. Ter. Intensiva. 2020;32(1):14-16. DOI: 10.5935/0103-507x.20200004.
  • Stollings J.L., Kotfis K., Chanques G., Pun B.T., Pandharipande P.P., Ely E.W. Delirium in critical illness: clinical manifestations, outcomes, and management. Intensive Care Med. 2021;47(10):1089-1103. DOI: 10.1007/s00134-021-06503-1.
  • Sinvani L., Delle Site C., Laumenede T., Patel V., Ardito S., Ilyas A. et al. Improving delirium detection in intensive care units: Multicomponent education and training program. J. Am. Geriatr. Soc. 2021;69(11):3249-3257. DOI: 10.1111/jgs.17419.
  • Kooken R.W.J., van den Berg M., Slooter A.J.C., Pop-Purceleanu M., van den Boogaard M. Factors associated with a persistent delirium in the intensive care unit: A retrospective cohort study. J. Crit. Care. 2021;66:132-137. DOI: 10.1016/j.jcrc.2021.09.001.
  • Wilson J.E., Mart M.F., Cunningham C., Shehabi Y., Girard T.D., MacLullich A.M.J. et al. Delirium. Nat. Rev. Dis. Primers. 2020;6(1):90. DOI: 10.1038/s41572-020-00223-4.
  • Ребенкова М.С., Гомбожапова А.Э., Роговская Ю.В., Рябов В.В., Кжышковска Ю.Г., Ким Б.Е. и др. Динамика CD68+ и stabilin-1+ ма-крофагальной инфильтрации в головном мозге у пациентов с инфарктом миокарда. Кардиология. 2019;59(4S):44-50. DOI: 10.18087/ cardio.2584. Rebenkova M.S., Gombozhapova A.E., Rogovskaya Y.V., Ryabov V.V., Kzhyshkowska Yu.G., Kim B.E. et al. Dynamics of brain CD68+ and sta-bilin-1+ macrophage infiltration in patients with myocardial infarction. Kar-diologiia. 2019;59(4S):44-50. (In Russ.). DOI: 10.18087/cardio.2584.
  • Kunze R., Marti H.H. Angioneurins - Key regulators of blood-brain barrier integrity during hypoxic and ischemic brain injury. Prog. Neurobiol. 2019;178:101611. DOI: 10.1016/j.pneurobio.2019.03.004.
  • Hill A.R., Spencer-Segal J.L. Glucocorticoids and the brain after critical illness. Endocrinology. 2021;162(3):bqaa242. DOI: 10.1210/endocr/ bqaa242.
  • Oh J., Shin J.E., Yang K.H., Kyeong S., Lee W.S., Chung T.S. et al. Cortical and subcortical changes in resting-state functional connectivity before and during an episode of postoperative delirium. Aust. N. Z. J. Psychiatry. 2019;53(8):794-806. DOI: 10.1177/0004867419848826.
  • Ibrahim K., McCarthy C.P., McCarthy K.J., Brown C.H., Needham D.M., Januzzi J.L. Jr. et al. Delirium in the Cardiac Intensive Care Unit. J. Am. Heart Assoc. 2018;7(4):e008568. DOI: 10.1161/JAHA.118.008568.
  • KirfelA., Menzenbach J., Guttenthaler V., Feggeler J., Mayr A., Coburn M. et al. Postoperative delirium after cardiac surgery of elderly patients as an independent risk factor for prolonged length of stay in intensive care unit and in hospital. Aging Clin. Exp. Res. 2021;33(11):3047-3056. DOI: 10.1007/s40520-021-01842-x.
  • Cha S., Brown C.H. Treating delirium in the intensive care unit: No easy answers. J. Thorac. Cardiovasc. Surg. 2020;159(5):1895-1898. DOI: 10.1016/j.jtcvs.2019.02.143.
  • Jackel M., Zotzmann V., Wengenmayer T., Duerschmied D., Biever P.M., Spieler D. et al. Incidence and predictors of delirium on the intensive care unit after acute myocardial infarction, insight from a retrospective registry. Catheter. Cardiovasc. Interv. 2021;98(6):1072-1081. DOI: 10.1002/ccd.29275.
  • Holland E.M., Moss T.J. Acute noncardiovascular illness in the Cardiac Intensive Care Unit. J. Am. Coll. Cardiol. 2017;69(16):1999-2007. DOI: 10.1016/j.jacc.2017.02.033.
  • Grotti S., Falsini G. Delirium in cardiac patients. Eur. Heart J. 2017;38(29):2244. DOI: 10.1093/eurheartj/ehx380.
  • Thomas C., Spank J., Weller S., Eschweiler G.W. Nonpharmaceutical concepts for prevention and treatment of delirium. Z. Gerontol. Geriatr. 2021;54(8):759-767. (In Germ.). DOI: 10.1007/s00391-021-01988-3.
  • Oh E.S., Fong T.G., Hshieh T.T., Inouye S.K. Delirium in older persons: Advances in diagnosis and treatment. JAMA. 2017;318(12):1161-1174. DOI: 10.1001/jama.2017.12067.
  • Woodhouse R., Burton J.K., Rana N., Pang Y.L., Lister J.E., Siddiqi N. Interventions for preventing delirium in older people in institutional long-term care. Cochrane Database Syst. Rev. 2019;4(4):CD009537. DOI: 10.1002/14651858.CD009537.pub3.
  • Fukata S., Kawabata Y., Fujishiro K., Kitagawa Y., Kuroiwa K., Akiyama H. et al. Haloperidol prophylaxis for preventing aggravation of postoperative delirium in elderly patients: A randomized, open-label prospective trial. Surg. Today. 2017;47(7):815-826. DOI: 10.1007/s00595-016-1441-2.
  • Hollinger A., Rust C.A., Riegger H., Gysi B., Tran F., Brugger J. et al. Ketamine vs. haloperidol for prevention of cognitive dysfunction and postoperative delirium: A phase IV multicentre randomised placebo-controlled double-blind clinical trial. J. Clin. Anesth. 2021;68:110099. DOI: 10.1016/j.jclinane.2020.110099.
  • Van den Boogaard M., Slooter A.J.C., Bruggemann R.J.M., Schoonho-ven L., Beishuizen A., Vermeijden J.W. et al. Effect of haloperidol on survival among critically ill adults with a high risk of delirium: The REDUCE Randomized Clinical Trial. JAMA. 2018;319(7):680-690. DOI: 10.1001/ jama.2018.0160.
  • Lin P., Zhang J., Shi F., Liang Z.A. Can haloperidol prophylaxis reduce the incidence of delirium in critically ill patients in intensive care units? A systematic review and meta-analysis. Heart Lung. 2020;49(3):265-272. DOI: 10.1016/j.hrtlng.2020.01.010.
  • Walker C.K., Gales M.A. Melatonin receptor agonists for delirium prevention. Ann. Pharmacother. 2017;51(1):72-78. DOI: 10.1177/1060028016665863.
  • Ng K.T., Teoh W.Y., Khor A.J. The effect of melatonin on delirium in hospitalised patients: A systematic review and meta-analyses with trial sequential analysis. J. Clin. Anesth. 2020;59:74-81. DOI: 10.1016/j. jclinane.2019.06.027.
  • Витик А.А., Шень Н.П. Органопротекторные свойства агониста а2-а-дренорецепторов дексмедетомидина (обзор литературы). Вестник интенсивной терапии имени А.И. Салтанова. 2018;4:74-79. Vitik A.A., Shen N.P. Organoprotective effects of the a2-adrenoreceptor agonist dexmedetomidine (literature review). Alexander Saltanov Intensive Care Herald. 2018;4:74-79. (In Russ.).
  • Skrobik Y., Duprey M.S., Hill N.S., Devlin J.W. Low-Dose Nocturnal Dexmedetomidine Prevents ICU Delirium. A Randomized, Placebo-controlled Trial. Am. J. Respir. Crit. Care Med. 2018;197(9):1147-1156. DOI: 10.1164/rccm.201710-1995OC.
  • Xu X.Q., Luo J.Z., Li X.Y., Tang H.Q., Lu W.H. Effects of perioperative rosuvastatin on postoperative delirium in elderly patients: A randomized, double-blind, and placebo-controlled trial. World. J. Clin. Cases. 2021;9(21):5909-5920. DOI: 10.12998/wjcc.v9.i21.5909.
  • Naef A.C., Jeitziner M.M., Gerber S.M., Jenni-Moser B., Muri R.M., Jakob S.M. et al. Virtual reality stimulation to reduce the incidence of delirium in critically ill patients: Study protocol for a randomized clinical trial. Trials. 2021;22(1):174. DOI: 10.1186/s13063-021-05090-2.
  • Cortés-Beringola A., Vicent L., Martín-Asenjo R., Puerto E., Domínguez-Pérez L., Maruri R. et al. Diagnosis, prevention, and management of delirium in the intensive cardiac care unit. Am. Heart J. 2021;232:164-176. DOI: 10.1016/j.ahj.2020.11.011.
  • Kohler J., Borchers F., Endres M., Weiss B., Spies C., Emmrich J.V. Cognitive deficits following intensive care. Dtsch. Arztebl. Int. 2019;116(38):627-634. DOI: 10.3238/arztebl.2019.0627.
  • Shivji S., Stabler S.N., Boyce K., Haljan G.J., McGloin R. Management of delirium in a medical and surgical intensive care unit. J. Clin. Pharm. Ther. 2021;46(3):669-676. DOI: 10.1111/jcpt.13319.
  • Hui D., Frisbee-Hume S., Wilson A., Dibaj S.S., Nguyen T., De La Cruz M. et al. Effect of Lorazepam With Haloperidol vs Haloperidol Alone on Agitated Delirium in Patients With Advanced Cancer Receiving Palliative Care: A Randomized Clinical Trial. JAMA. 2017;318(11):1047-1056. DOI: 10.1001/jama.2017.11468.
  • Devlin J.W., Roberts R.J., Fong J.J., Skrobik Y., Riker R.R., Hill N.S. et al. Efficacy and safety of quetiapine in critically ill patients with delirium: A prospective, multicenter, randomized, double-blind, placebo-controlled pilot study. Crit. Care Med. 2010;38(2):419-427. DOI: 10.1097/ CCM.0b013e3181b9e302.
  • Boettger S., Friedlander M., Breitbart W., Passik S. Aripiprazole and haloperidol in the treatment of delirium. Aust. N. Z. J. Psychiatry. 2011;45(6):477-482. DOI: 10.3109/00048674.2011.543411.
  • Wang S., Hong Y., Li S., Kuriyama A., Zhao Y., Hu J. et al. Effect of dexmedetomidine on delirium during sedation in adult patients in intensive care units: A systematic review and meta-analysis. J. Clin. Anesth. 2021;69:110157. DOI: 10.1016/j.jclinane.2020.110157.
Еще
Статья научная
SciUp 2024 © 2024 ©